Veerle Bossuyt Selected Research

Veerle Bossuyt Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 03/2011
20	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2011
4	Pathologic Complete Response 02/2016 - 05/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2005
3	Triple Negative Breast Neoplasms 12/2021 - 01/2013
3	Carcinoma (Carcinomatosis) 11/2018 - 09/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018 - 09/2017
1	Schmid-Fraccaro syndrome 01/2022
1	Avian Reticuloendotheliosis 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Ductal Carcinoma 11/2018
1	Carcinoma in Situ 10/2018
1	Mesothelioma 11/2017
1	Melanoma (Melanoma, Malignant) 11/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017
1	Brain Neoplasms (Brain Tumor) 11/2017
1	Extranodal Extension 09/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 03/2017
1	Adenocarcinoma 09/2013
1	Lymphatic Metastasis 02/2010

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 10/2018 - 03/2011
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2013
3	Estrogen ReceptorsIBA 01/2018 - 03/2011
3	Trastuzumab (Herceptin)FDA Link 02/2016 - 05/2014
3	130-nm albumin-bound paclitaxelIBA 02/2016 - 05/2014
2	Biological ProductsIBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2016
2	Phenobarbital (Luminal)FDA Link 01/2018 - 01/2013
2	Hematoxylin (Haematoxylon)IBA 09/2017 - 03/2011
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2017 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2017 - 09/2013
2	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2015 - 03/2011
2	Monoclonal AntibodiesIBA 04/2015 - 05/2014
1	CytokinesIBA 01/2022
1	ChromatinIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Capecitabine (Xeloda)FDA Link 12/2021
1	AnthracyclinesIBA 12/2021
1	taxaneIBA 12/2021
1	TropomyosinIBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	larotrectinibIBA 10/2021
1	entrectinibIBA 10/2021
1	CateninsIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	atezolizumabIBA 01/2020
1	human ERBB2 proteinIBA 01/2019
1	ORALIT (ORS)IBA 11/2018
1	Pharmaceutical PreparationsIBA 04/2016
1	Bevacizumab (Avastin)FDA Link 02/2016
1	B7-H1 AntigenIBA 04/2015
1	Hormones (Hormone)IBA 04/2015
1	Immune Checkpoint ProteinsIBA 04/2015
1	Carboplatin (JM8)FDA LinkGeneric 05/2014
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Insulin-Like PeptidesIBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	OsseusIBA 02/2010
1	Dihydrotachysterol (AT 10)IBA 07/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2011
8	Neoadjuvant Therapy 01/2020 - 05/2014
6	Drug Therapy (Chemotherapy) 12/2021 - 02/2010
2	Segmental Mastectomy (Lumpectomy) 01/2017 - 08/2015
1	Mastectomy (Mammectomy) 01/2018
1	Immunotherapy 11/2017
1	Combination Drug Therapy (Combination Chemotherapy) 02/2016
1	Biological Therapy 02/2016
1	Aftercare (After-Treatment) 09/2015
1	Curettage 09/2013